Emcure Pharma Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 2.94125
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

In 2 Starfolio Baskets

about

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

2009.60 10.90 (0.55%)

New 52W High in past week

220.4K

NSE+BSE Volume

NSE 12 Aug, 2026 3:31 PM (IST)

Target Upgrade

Motilal Oswal retains a 'Buy' call on Emcure, raises target to Rs 2,300 citing a niche portfolio See details

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

69.8 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

2,214

1Yr Price target upside is 10%

7 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

New 52W High in past week

SWOT Analysis

Emcure Pharma Live Price Chart

Emcure Pharma Live Price Chart